What is the recommended dose of Colistin (polymyxin E) for a patient with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colistin Dosing in Renal Impairment

For patients with impaired renal function, administer a loading dose of 9 million IU (MU) of colistin methanesulfonate (CMS) regardless of renal function, followed by maintenance doses adjusted according to creatinine clearance: 2.5-3.8 mg/kg divided into 2 doses for mild impairment (CrCl 50-79 mL/min), 2.5 mg/kg once daily or divided into 2 doses for moderate impairment (CrCl 30-49 mL/min), and 1.5 mg/kg every 36 hours for severe impairment (CrCl 10-29 mL/min). 1

Loading Dose (All Patients)

  • Always administer a loading dose of 9 million IU (equivalent to 5 mg/kg) regardless of renal function to rapidly achieve therapeutic levels 2, 3, 4
  • The loading dose is critical because colistin has a relatively long half-life compared to dosing intervals, and the inactive prodrug CMS converts slowly to active colistin 3, 5
  • This loading dose applies equally to patients with normal renal function, impaired renal function, and those on renal replacement therapy 3

Maintenance Dosing Based on Renal Function

Normal Renal Function (CrCl ≥80 mL/min)

  • Maintenance dose: 4.5 million IU every 12 hours (total 9 MU/day) 2, 4
  • Alternative weight-based dosing: 2.5-5 mg/kg/day divided into 2-4 doses 1
  • For critically ill patients with severe sepsis/septic shock: 4.5 million IU every 12 hours is the recommended regimen 3

Mild Renal Impairment (CrCl 50-79 mL/min)

  • Maintenance dose: 2.5-3.8 mg/kg divided into 2 doses per day 1
  • Dose should be individually adjusted according to creatinine clearance 3

Moderate Renal Impairment (CrCl 30-49 mL/min)

  • Maintenance dose: 2.5 mg/kg once daily or divided into 2 doses per day 1

Severe Renal Impairment (CrCl 10-29 mL/min)

  • Maintenance dose: 1.5 mg/kg every 36 hours 1
  • Alternative dosing from National Kidney Foundation: 3.0-5.0 mg/kg IV every 24-36 hours 3

Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT)

  • Administer at least 9 million IU/day 3
  • Consider polymyxin B as an alternative, as it does not require dose adjustment during CRRT and may have lower nephrotoxicity 3, 6

Intermittent Hemodialysis

  • Maintenance dose: 2 million IU every 12 hours after the normal loading dose 3
  • Alternative dosing: 3.0-5.0 mg/kg IV every 24 hours 3
  • Schedule dialysis toward the end of a colistin dosage interval 3

Continuous Ambulatory Peritoneal Dialysis (CAPD)

  • Loading dose of 300 mg colistin base activity (CBA) on day 1, followed by maintenance dose of 150-200 mg CBA daily 7
  • CAPD clearance is low for both CMS and colistin, so doses should not be increased during CAPD 7

Administration Methods

  • Administer as a 4-hour infusion to optimize pharmacokinetic/pharmacodynamic properties 3, 4
  • For direct intermittent IV administration: slowly inject one-half of total daily dose over 3-5 minutes every 12 hours 1
  • For continuous infusion: inject first half over 3-5 minutes, then infuse remaining half over 22-23 hours 1

Critical Monitoring Requirements

  • Monitor renal function closely at baseline and 2-3 times per week during treatment 3
  • This is a strong recommendation due to the significant risk of acute kidney injury, which is a major factor related to clinical failure and mortality 2, 4
  • Acute kidney injury during colistin treatment is dose-dependent but most nephrotoxicity is reversible within one week 6

Important Dosing Considerations

Dosing Units and Conversions

  • Colistin is administered as colistimethate sodium (CMS), an inactive prodrug 3, 4
  • 1 million IU of colistin = 80 mg of CMS 3, 6
  • Dosage should be based on ideal body weight in obese individuals 1

Common Pitfalls to Avoid

  • Do not skip the loading dose in patients with renal impairment - the loading dose is essential regardless of renal function 3
  • Many clinicians inappropriately fail to adjust maintenance doses according to renal function, particularly in patients with renal impairment 8
  • Do not increase doses during CAPD, as clearance by peritoneal dialysis is minimal 7
  • The recommended doses may be inadequate for pathogens with MIC ≥1 mg/L, particularly Pseudomonas species; consider combination therapy in these cases 2, 9

Alternative: Polymyxin B

  • Consider polymyxin B as an alternative in patients with renal impairment, particularly those on CRRT 6
  • Polymyxin B has significantly lower nephrotoxicity (11.8% vs 39.3% with colistin) 6
  • Polymyxin B requires no dose adjustment during CRRT and is administered as the active drug 6
  • Loading dose: 2-2.5 mg/kg; maintenance: 1.5-3 mg/kg/day with no adjustment needed for CRRT 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colistin Dosage Administration in Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colistin Dosage Guidelines for Patients with Normal Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colistin: how should it be dosed for the critically ill?

Seminars in respiratory and critical care medicine, 2015

Guideline

Polymyxin B in Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.